<VariationArchive RecordType="classified" VariationID="930504" VariationName="NM_022845.3(CBFB):c.295_296dup (p.Pro100fs)" VariationType="Duplication" Accession="VCV000930504" Version="5" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2023-06-04" DateCreated="2020-07-04" MostRecentSubmission="2023-04-30">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="919670" VariationID="930504">
      <GeneList>
        <Gene Symbol="CBFB" FullName="core-binding factor subunit beta" GeneID="865" HGNC_ID="HGNC:1539" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16q22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="67029149" stop="67101058" display_start="67029149" display_stop="67101058" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="67063049" stop="67134960" display_start="67063049" display_stop="67134960" Strand="+" />
          </Location>
          <OMIM>121360</OMIM>
          <Haploinsufficiency last_evaluated="2012-02-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CBFB">No evidence available</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-02-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CBFB">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_022845.3(CBFB):c.295_296dup (p.Pro100fs)</Name>
      <CanonicalSPDI>NC_000016.10:67066693:GC:GCGC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>16q22.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="67066693" stop="67066694" display_start="67066693" display_stop="67066694" variantLength="2" positionVCF="67066693" referenceAlleleVCF="G" alternateAlleleVCF="GGC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="67100596" stop="67100597" display_start="67100596" display_stop="67100597" variantLength="2" positionVCF="67100596" referenceAlleleVCF="G" alternateAlleleVCF="GGC" />
      </Location>
      <ProteinChange>P61fs</ProteinChange>
      <ProteinChange>P100fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.67066694_67066695dup" Assembly="GRCh38">
            <Expression>NC_000016.10:g.67066694_67066695dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.67100597_67100598dup" Assembly="GRCh37">
            <Expression>NC_000016.9:g.67100597_67100598dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009281.1" sequenceAccession="NG_009281" sequenceVersion="1" change="g.42548_42549dup">
            <Expression>NG_009281.1:g.42548_42549dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001368707.1" sequenceAccession="NM_001368707" sequenceVersion="1" change="c.178_179dup">
            <Expression>NM_001368707.1:c.178_179dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001355636.1" sequenceAccession="NP_001355636" sequenceVersion="1" change="p.Pro61fs">
            <Expression>NP_001355636.1:p.Pro61fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001368709.1" sequenceAccession="NM_001368709" sequenceVersion="1" change="c.178_179dup">
            <Expression>NM_001368709.1:c.178_179dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001355638.1" sequenceAccession="NP_001355638" sequenceVersion="1" change="p.Pro61fs">
            <Expression>NP_001355638.1:p.Pro61fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001755.3" sequenceAccession="NM_001755" sequenceVersion="3" change="c.295_296dup">
            <Expression>NM_001755.3:c.295_296dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001746.1" sequenceAccession="NP_001746" sequenceVersion="1" change="p.Pro100fs">
            <Expression>NP_001746.1:p.Pro100fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_022845.3" sequenceAccession="NM_022845" sequenceVersion="3" change="c.295_296dup" MANESelect="true">
            <Expression>NM_022845.3:c.295_296dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_074036.1" sequenceAccession="NP_074036" sequenceVersion="1" change="p.Pro100fs">
            <Expression>NP_074036.1:p.Pro100fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001368710.1" sequenceAccession="NM_001368710" sequenceVersion="1" change="c.283-15519_283-15518dup">
            <Expression>NM_001368710.1:c.283-15519_283-15518dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001368708.1" sequenceAccession="NM_001368708" sequenceVersion="1" change="c.283-15519_283-15518dup">
            <Expression>NM_001368708.1:c.283-15519_283-15518dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1364" sequenceAccession="LRG_1364">
            <Expression>LRG_1364:g.42548_42549dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1364t1" sequenceAccession="LRG_1364t1">
            <Expression>LRG_1364t1:c.295_296dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1364p1" sequenceAccession="LRG_1364p1" change="p.Pro100fs">
            <Expression>LRG_1364p1:p.Pro100fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1364t2" sequenceAccession="LRG_1364t2">
            <Expression>LRG_1364t2:c.295_296dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1364p2" sequenceAccession="LRG_1364p2" change="p.Pro100fs">
            <Expression>LRG_1364p2:p.Pro100fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="121360.0003" DB="OMIM" />
        <XRef Type="rs" ID="1961069899" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_022845.3(CBFB):c.295_296dup (p.Pro100fs) AND Acute myeloid leukemia" Accession="RCV001196219" Version="2">
        <ClassifiedConditionList TraitSetID="6288">
          <ClassifiedCondition DB="MedGen" ID="C0023467">Acute myeloid leukemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-07-26" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_022845.3(CBFB):c.295_296dup (p.Pro100fs) AND Cleidocranial dysplasia 2" Accession="RCV002293506" Version="2">
        <ClassifiedConditionList TraitSetID="80925">
          <ClassifiedCondition DB="MedGen" ID="C5774243">Cleidocranial dysplasia 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2023-04-25" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-07-26" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2020-07-04" MostRecentSubmission="2023-04-30">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Uncertain significance</Description>
        <Citation Type="general">
          <ID Source="PubMed">36241386</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="80925" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="66219" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Cleidocranial dysplasia 2</ElementValue>
                <XRef ID="MONDO:0859307" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CLCD2</ElementValue>
                <XRef Type="MIM" ID="620099" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CCD2</ElementValue>
                <XRef Type="MIM" ID="620099" DB="OMIM" />
              </Symbol>
              <XRef ID="C5774243" DB="MedGen" />
              <XRef ID="MONDO:0859307" DB="MONDO" />
              <XRef Type="MIM" ID="620099" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6288" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="15736" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Acute myeloid leukemia, adult</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">AML adult</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acute myelogenous leukemia</ElementValue>
                <XRef ID="Acute+Myeloid+Leukemia%2C+Adult/204" DB="Genetic Alliance" />
                <XRef ID="HP:0004808" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acute non-lymphocytic leukemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acute granulocytic leukemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Leukemia, acute myeloid, somatic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Leukemia, acute myelogenous, somatic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Acute myeloid leukemia</ElementValue>
                <XRef ID="HP:0004808" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0018874" DB="MONDO" />
                <XRef ID="519" DB="Orphanet" />
                <XRef ID="17788007" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">AML</ElementValue>
                <XRef ID="GTR000500636" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="601626" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism">Constitutively activated FLT3</Attribute>
                <XRef ID="GTR000552464" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">CEBPA-associated familial acute myeloid leukemia (AML) is defined as the presence of a heterozygous germline CEBPA pathogenic variant in an individual with AML and/or family in which more than one individual has AML. In contrast, sporadic CEBPA-associated AML is defined as AML in which a CEBPA pathogenic variant(s) is identified in leukemic cells but not in the non-leukemic cells. In the majority of individuals, the age of onset of familial AML appears to be earlier than sporadic AML; disease onset has been reported in persons as young as age 1.8 years and up to age 50 years. The prognosis of CEBPA-associated familial AML appears to be favorable compared with sporadic CEBPA-associated AML. Individuals with CEBPA-associated familial AML who have been cured of their initial disease may be at greater risk of developing additional independent leukemic episodes, in addition to the risk of relapse from preexisting clones.</Attribute>
                <XRef ID="NBK47457" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20963938</ID>
                <ID Source="BookShelf">NBK47457</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="NCCN, 2011">
                <ID Source="PubMed">22138009</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESMO, 2013">
                <ID Source="PubMed">23970018</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">33226740</ID>
                <ID Source="BookShelf">NBK564234</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESMO, 2020">
                <ID Source="PubMed">32171751</ID>
              </Citation>
              <XRef ID="519" DB="Orphanet" />
              <XRef ID="C0023467" DB="MedGen" />
              <XRef ID="D015470" DB="MeSH" />
              <XRef ID="MONDO:0018874" DB="MONDO" />
              <XRef Type="MIM" ID="601626" DB="OMIM" />
              <XRef Type="primary" ID="HP:0004808" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0001914" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0004843" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0005516" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0006724" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0006728" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2694850" SubmissionDate="2020-11-24" DateLastUpdated="2020-07-04" DateCreated="2020-07-04">
        <ClinVarSubmissionID localKey="NM_022845.2:c.295_296dupGC|OMIM:601626" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001366769" DateUpdated="2020-07-04" DateCreated="2020-07-04" Type="SCV" Version="2" SubmitterName="Centre for Mendelian Genomics, University Medical Centre Ljubljana" OrgID="505952" OrganizationCategory="clinic" OrgAbbreviation="CMG-UMCL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-07-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Comment>This variant was classified as: Uncertain significance. The available evidence on this variant's pathogenicity is insufficient or conflicting. The following ACMG criteria were applied in classifying this variant: PM2.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_022845.2:c.295_296dupGC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="601626" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8622351</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5054806" SubmissionDate="2022-10-24" DateLastUpdated="2023-04-30" DateCreated="2022-10-29">
        <ClinVarSubmissionID localKey="121360.0003_CLEIDOCRANIAL DYSPLASIA 2" title="CBFB, 2-BP DUP, NT295_CLEIDOCRANIAL DYSPLASIA 2" />
        <ClinVarAccession Accession="SCV002586990" DateUpdated="2023-04-30" DateCreated="2022-10-29" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-25">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a woman and her mother (patients 3 and 4) with cleidocranial dysplasia (CLCD2; 620099), Beyltjens et al. (2023) identified heterozygosity for a 2-bp duplication (c.295_296dup, NM_022845.3) in exon 4 of the CBFB gene, causing a frameshift predicted to result in a premature termination codon (Pro100LeufsTer3). The duplication was not found in the dbSNP, ExAC, or gnomAD databases. The daughter had right-sided 'clavicula bipartita' and 4 supernumerary teeth; her mother had aplasia of the clavicles and broad thumbs.</Attribute>
              <Citation>
                <ID Source="PubMed">36241386</ID>
              </Citation>
              <XRef DB="OMIM" ID="620099" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CBFB" />
          </GeneList>
          <Name>CBFB, 2-BP DUP, NT295</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DUP, NT295</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="121360.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">CLEIDOCRANIAL DYSPLASIA 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2694850" TraitType="Disease" MappingType="XRef" MappingValue="601626" MappingRef="OMIM">
        <MedGen CUI="C0023467" Name="Acute myeloid leukemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5054806" TraitType="Disease" MappingType="Name" MappingValue="CLEIDOCRANIAL DYSPLASIA 2" MappingRef="Preferred">
        <MedGen CUI="C5774243" Name="Cleidocranial dysplasia 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

